NH-160030

N/A

Report date: 2025/03/03 16:44:52
NME

Base Information

Drug NameNH-160030
Drug Alias NameNH160030NH-160030
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMu opioid receptor agonists
TargetsMu opioid receptor
Therapy Area/IndicationsCancer Pain
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesJiangsu Nhwa Pharmaceutical Co LtdShanghai Shujing Biotechnology Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesShanghai Shujing Biotechnology Co LtdJiangsu Nhwa Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsCancer Pain
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A